FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021788900> ?p ?o ?g. }

• W2021788900 endingPage "375" @default.
• W2021788900 startingPage "369" @default.
• W2021788900 abstract "Background. Nafcillin and cefazolin are considered first-line therapy for most infections with methicillin-susceptible Staphylococcus aureus (MSSA), and recent studies have suggested similar clinical efficacy. Limited data are available on the comparative tolerability of these agents. Methods. In this retrospective cohort analysis of patients treated with either nafcillin or cefazolin for MSSA infection in the outpatient parenteral antimicrobial therapy clinic at Massachusetts General Hospital from 2007 to 2011, the frequency of premature antimicrobial discontinuation (PAD) and drug-emergent events (DEEs) was calculated. Results. Three hundred sixty-six and 119 patients were treated with nafcillin or cefazolin, respectively. The median anticipated duration of therapy was comparable at 28 (interquartile range [IQR], 16–37) and 29 (IQR, 24–39) days, respectively, for those treated with nafcillin and cefazolin. Fewer patients completed the prespecified treatment course with nafcillin than with cefazolin (PAD rate, 33.8% vs 6.7%; P < .0001). The hazard ratio for PAD in the nafcillin vs cefazolin groups was 2.81 (95% confidence interval [CI], 1.26–3.68). More patients in the nafcillin group developed rash (13.9% vs 4.2%; P = .002), renal dysfunction (11.4% vs 3.3%; P = .006), and liver function abnormalities (8.1% vs 1.6%; P = .01). Overall rates of DEEs per 1000 patient-days were 16.9 (95% CI, 10.4–27.3) and 4.8 (95% CI, 1.1–10.2), respectively. In 9 cases of nafcillin discontinuation, treatment was changed to cefazolin; all 9 completed treatment with no further observed DEEs. Conclusions. Nafcillin treatment was associated with higher rates of both PAD as well as DEEs compared with cefazolin treatment. This difference in tolerability, in addition to efficacy and cost, should be considered when decisions for outpatient parenteral MSSA treatment are made." @default.
• W2021788900 created "2016-06-24" @default.
• W2021788900 creator A5006342786 @default.
• W2021788900 creator A5032938040 @default.
• W2021788900 creator A5039406963 @default.
• W2021788900 creator A5087244157 @default.
• W2021788900 date "2014-04-29" @default.
• W2021788900 modified "2023-10-09" @default.
• W2021788900 title "Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting" @default.
• W2021788900 cites W1516573983 @default.
• W2021788900 cites W1572509795 @default.
• W2021788900 cites W1690595801 @default.
• W2021788900 cites W1891958735 @default.
• W2021788900 cites W1899878653 @default.
• W2021788900 cites W1973359676 @default.
• W2021788900 cites W1975781941 @default.
• W2021788900 cites W1977027746 @default.
• W2021788900 cites W1990278006 @default.
• W2021788900 cites W2007059813 @default.
• W2021788900 cites W2015115293 @default.
• W2021788900 cites W2022907333 @default.
• W2021788900 cites W2023456927 @default.
• W2021788900 cites W2045190713 @default.
• W2021788900 cites W2064059084 @default.
• W2021788900 cites W2079575346 @default.
• W2021788900 cites W2110904468 @default.
• W2021788900 cites W2110987545 @default.
• W2021788900 cites W2118546214 @default.
• W2021788900 cites W2119591129 @default.
• W2021788900 cites W2125675160 @default.
• W2021788900 cites W2141994303 @default.
• W2021788900 cites W2145826475 @default.
• W2021788900 cites W2171665402 @default.
• W2021788900 cites W2607595634 @default.
• W2021788900 cites W4362212545 @default.
• W2021788900 cites W4379370543 @default.
• W2021788900 doi "https://doi.org/10.1093/cid/ciu301" @default.
• W2021788900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4110443" @default.
• W2021788900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24785233" @default.
• W2021788900 hasPublicationYear "2014" @default.
• W2021788900 type Work @default.
• W2021788900 sameAs 2021788900 @default.
• W2021788900 citedByCount "73" @default.
• W2021788900 countsByYear W20217889002014 @default.
• W2021788900 countsByYear W20217889002015 @default.
• W2021788900 countsByYear W20217889002016 @default.
• W2021788900 countsByYear W20217889002017 @default.
• W2021788900 countsByYear W20217889002018 @default.
• W2021788900 countsByYear W20217889002019 @default.
• W2021788900 countsByYear W20217889002020 @default.
• W2021788900 countsByYear W20217889002021 @default.
• W2021788900 countsByYear W20217889002022 @default.
• W2021788900 countsByYear W20217889002023 @default.
• W2021788900 crossrefType "journal-article" @default.
• W2021788900 hasAuthorship W2021788900A5006342786 @default.
• W2021788900 hasAuthorship W2021788900A5032938040 @default.
• W2021788900 hasAuthorship W2021788900A5039406963 @default.
• W2021788900 hasAuthorship W2021788900A5087244157 @default.
• W2021788900 hasBestOaLocation W20217889001 @default.
• W2021788900 hasConcept C119060515 @default.
• W2021788900 hasConcept C126322002 @default.
• W2021788900 hasConcept C141071460 @default.
• W2021788900 hasConcept C167135981 @default.
• W2021788900 hasConcept C174802600 @default.
• W2021788900 hasConcept C197934379 @default.
• W2021788900 hasConcept C2778353156 @default.
• W2021788900 hasConcept C2778375690 @default.
• W2021788900 hasConcept C2778715236 @default.
• W2021788900 hasConcept C2780515650 @default.
• W2021788900 hasConcept C3019249092 @default.
• W2021788900 hasConcept C42219234 @default.
• W2021788900 hasConcept C501593827 @default.
• W2021788900 hasConcept C71924100 @default.
• W2021788900 hasConcept C86803240 @default.
• W2021788900 hasConcept C89423630 @default.
• W2021788900 hasConceptScore W2021788900C119060515 @default.
• W2021788900 hasConceptScore W2021788900C126322002 @default.
• W2021788900 hasConceptScore W2021788900C141071460 @default.
• W2021788900 hasConceptScore W2021788900C167135981 @default.
• W2021788900 hasConceptScore W2021788900C174802600 @default.
• W2021788900 hasConceptScore W2021788900C197934379 @default.
• W2021788900 hasConceptScore W2021788900C2778353156 @default.
• W2021788900 hasConceptScore W2021788900C2778375690 @default.
• W2021788900 hasConceptScore W2021788900C2778715236 @default.
• W2021788900 hasConceptScore W2021788900C2780515650 @default.
• W2021788900 hasConceptScore W2021788900C3019249092 @default.
• W2021788900 hasConceptScore W2021788900C42219234 @default.
• W2021788900 hasConceptScore W2021788900C501593827 @default.
• W2021788900 hasConceptScore W2021788900C71924100 @default.
• W2021788900 hasConceptScore W2021788900C86803240 @default.
• W2021788900 hasConceptScore W2021788900C89423630 @default.
• W2021788900 hasIssue "3" @default.
• W2021788900 hasLocation W20217889001 @default.
• W2021788900 hasLocation W20217889002 @default.
• W2021788900 hasLocation W20217889003 @default.
• W2021788900 hasLocation W20217889004 @default.
• W2021788900 hasOpenAccess W2021788900 @default.
• W2021788900 hasPrimaryLocation W20217889001 @default.

• next